1. Home
  2. KZR

KZR

Kezar Life Sciences Inc.

Logo Kezar Life Sciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 2:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Founded: 2015 Country:
N/A
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 59.4M IPO Year: 2018
Target Price: $11.00 AVG Volume (30 days): 770.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.40 EPS Growth: N/A
52 Week Low/High: $0.67 - $3.13 Next Earning Date: 01-01-0001
Revenue: $7,000,000 Revenue Growth: N/A
Revenue Growth (this year): -66.33% Revenue Growth (next year): 42.85%

Share on Social Networks: